PTP — Pentixapharm Holding AG Cashflow Statement
0.000.00%
- €71.99m
- €48.76m
- €6.82m
Annual cashflow statement for Pentixapharm Holding AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2024 December 31st | |
---|---|
Period Length: | 41 W |
Source: | ARS |
Standards: | IFRS |
Status: | Final |
Net Income/Starting Line | -12.8 |
Depreciation | |
Deferred Taxes | |
Non-Cash Items | -0.036 |
Other Non-Cash Items | |
Changes in Working Capital | -6.78 |
Change in Accounts Receivable | |
Change in Other Assets | |
Change in Accounts Payable | |
Cash from Operating Activities | -4.33 |
Capital Expenditures | -0.001 |
Purchase of Fixed Assets | |
Other Investing Cash Flow Items | 8.24 |
Acquisition of Business | |
Other Investing Cash Flow | |
Cash from Investing Activities | 8.24 |
Financing Cash Flow Items | 19.3 |
Other Financing Cash Flow | |
Cash from Financing Activities | 19.3 |
Beginning Cash Balance | |
Ending Cash Balance | |
Net Change in Cash | 23.2 |